Skip to main content
Premium Trial:

Request an Annual Quote

Farewell, Compaq, Hello IBM: Celera and ABI Overhaul Computer Infrastructure

NEW YORK, Sept. 26-Celera Genomics and Applied Biosystems are overhauling their joint computer infrastructure with hardware and operating systems from IBM and storage systems from EMC Corporation, the companies said today.

 

With this deal, the two Applera companies bid goodbye to Compaq, their  longtime computing partner.

 

Beginning this month, IBM will install a supercomputer structure in the companies' Rockville headquarters that includes 12 p690 systems running AIX, IBM's UNIX system. With a projected peak speed of two teraflops, the fully installed system is expected to be one of the fastest in the world.

 

The Applera businesses have also purchased 150 terabytes of networked storage from EMC, and will use EMC open software for data management, creating a global storage area network that will consolidate its massive biological databases.

 

Financial specifics of the two deals were not revealed.

 

Celera will use the new IBM system to identify and validate drug targets and potential diagnostic markers. ABI will rely on the infrastructure to support its database and information products, including the Celera DiscoverySystem mammalian genome platform.

 

The two Applera businesses also plan to work collaboratively with the computer giant to improve drug target discovery and develop and co-market new life sciences applications for IBM products.

 

The overhaul will better suit Applera's newly reorganized divisions, said a company representative in a statement. Last spring, Celera gave up the gene sequencing business to focus on drug discovery.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.